Skip to main content

Table 4 Unadjusted proportions and adjusted odds ratios (multivariate logistic regression) of anxiety problems managed with different strategies, by GP characteristics

From: Anxiety management in Australian general practice: an analysis of encounters from 2006 – 2016

 

Benzodiazepines

SSRIs or SNRIs

CAE

Psychologist Referral

Variable

Proportion

(95%CI)

Adjusted OR

(95%CI)

Proportion

(95% CI)

Adjusted OR

(95%CI)

Proportion

(95% CI)

Adjusted OR

(95%CI)

Proportion

(95% CI)

Adjusted OR

(95%CI)

Practice location

 

p = .641

 

p = .003

 

p = .035

 

p = .004

 Major city

29.2% (28.2–30.2)

1.04 (0.89–1.23)

45.2% (44.1–46.2)

1.26 (1.07–1.48)

12.8% (12.3–13.4)

1.19 (0.97–1.47)

20.6% (19.8–21.3)

0.90 (0.77–1.05)

 Inner regional

32.0% (30.1–34.0)

0.99 (0.83–1.18)

39.8% (37.9–41.7)

1.09 (0.92–1.30)

10.7% (9.8–11.7)

1.02 (0.81–1.28)

23.2% (21.8–24.6)

1.08 (0.91–1.28)

 Outer regional/remote

32.7% (29.8–35.6)

Ref group

39.2% (36.2–42.3)

Ref group

9.9% (8.5–11.4)

Ref group

21.3% (19.3–23.4)

Ref group

Practice size

 

p = .315

 

p = .658

 

p = .017

 

p = .001

 Solo GP

42.0% (38.1–46.0)

Ref group

39.3% (35.8–42.9)

Ref group

6.5% (5.4–7.6)

Ref group

14.4% (12.7–16.1)

Ref group

 2–4 GPs

31.2% (29.5–32.9)

0.87 (0.71–1.07)

44.4% (42.7–46.1)

1.07 (0.88–1.29)

11.2% (10.4–12.0)

1.33 (1.05–1.70)

20.8% (19.7–21.9)

1.46 (1.21–1.76)

 5–9 GPs

27.9% (26.7–29.1)

0.82 (0.67–1.00)

43.9% (42.6–45.3)

1.08 (0.90–1.30)

13.5% (12.7–14.3)

1.48 (1.17–1.87)

21.8% (20.9–22.7)

1.40 (1.17–1.68)

 10–14 GPs

26.2% (24.3–28.0)

0.82 (0.66–1.02)

45.7% (43.4–47.9)

1.15 (0.93–1.40)

14.0% (12.7–15.2)

1.39 (1.08–1.79)

22.9% (21.4–24.5)

1.36 (1.11–1.67)

 15 + GPs

28.0% (24.4–31.5)

0.80 (0.62–1.04)

42.5% (38.8–46.2)

1.02 (0.80–1.31)

13.5% (11.5–15.4)

1.30 (0.97–1.73)

23.9% (21.3–26.6)

1.56 (1.23–1.97)

GP sex

 

p < .0001

 

p < .0001

 

p < .0001

 

p < .0001

 Male

38.0% (36.7–39.3)

Ref group

39.1% (37.9–40.4)

Ref group

9.7% (9.1–10.3)

Ref group

18.6% (17.8–19.4)

Ref group

 Female

20.8% (19.9–21.8)

0.56 (0.51–0.62)

48.9% (47.6–50.2)

1.29 (1.18–1.41)

15.1% (14.4–15.8)

1.30 (1.16–1.44)

23.9% (23.0–24.8)

1.22 (1.11–1.33)

GP age

 

p < .0001

 

p < .0001

 

p < .0001

 

p < .0001

 < 45 years

22.1% (20.9–23.3)

Ref group

45.5% (43.7–47.2)

Ref group

16.4% (15.4–17.4)

Ref group

26.1% (24.9–27.3)

Ref group

 45–59 years

28.4% (27.3–29.6)

1.18 (1.06–1.31)

45.8% (44.5–47.1)

1.08 (0.97–1.19)

12.4% (11.7–13.0)

0.89 (0.80–1.00)

20.9% (20.1–21.7)

0.82 (0.74–0.90)

 60 years + 

40.6% (38.6–42.7)

1.65 (1.44–1.88)

37.8% (36.0–39.6)

0.82 (0.72–0.94)

8.0% (7.3–8.8)

0.68 (0.58–0.81)

16.8% (15.6–18.0)

0.70 (0.62–0.80)

Data collection year

n/a

p < .0001

0.94 (0.92–0.95)

 

p = .009

0.98 (0.96–1.00)

 

p < .0001

1.09 (1.07–1.11)

n/a

p < .0001

1.05 (1.03–1.06)

  1. OR Odds ratio, SSRIs Selective serotonin reuptake inhibitors, SNRIs Serotonin noradrenalin reuptake inhibitors, CAE Counselling / advice / education, GP General practitioner